[Answered] Both of the South African australopithecines species showed the hominids traits of bipedalism and ...

This topic contains a solution. Click here to go to the answer

Author Question: Both of the South African australopithecines species showed the hominids traits of bipedalism and ... (Read 45 times)

MGLQZ

Hero Member
Posts: 579

on: Aug 11, 2018

Both of the South African australopithecines species showed the hominids traits of bipedalism and short canines.

Indicate whether the statement is true or false

Question 2

The ________ model posits that all or most archaic humans from around the Old World contributed to the modern gene pool.

Fill in the blank(s) with correct word

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

jomama

Sr. Member
Posts: 346

Reply #1 on: Aug 11, 2018

Answer to Question 1

TRUE

Answer to Question 2

regional-continuity

MGLQZ

Member
Posts: 579

Reply 2 on: Aug 11, 2018

Excellent

frankwu0507

Member
Posts: 322

Reply 3 on: Yesterday

Wow, this really help

« previous next »

Did you know?

People who have myopia, or nearsightedness, are not able to see objects at a distance but only up close. It occurs when the cornea is either curved too steeply, the eye is too long, or both. This condition is progressive and worsens with time. More than 100 million people in the United States are nearsighted, but only 20% of those are born with the condition. Diet, eye exercise, drug therapy, and corrective lenses can all help manage nearsightedness.

Did you know?

There are 60,000 miles of blood vessels in every adult human.

Did you know?

In 1835 it was discovered that a disease of silkworms known as muscardine could be transferred from one silkworm to another, and was caused by a fungus.

Did you know?

Blood is approximately twice as thick as water because of the cells and other components found in it.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.